Drug firm Zydus Cadila has said it is looking to supply its Covid-19 vaccine ZyCoV-D by the middle to end of September, adding the pricing of the dose will be announced in the next one or two weeks.

The company's indigenously developed needle-free three-dose Covid-19 vaccine ZyCoV-D was granted emergency use authorisation (EUA) by the drug regulator on August 20, making it the first vaccine to be administered to beneficiaries in the age group of 12-18 years in the country. "Post the emergency use authorisation, now we will work closely with the regulatory authorities to work on the pricing and modality of delivery of the doses of our vaccine. In the next one or two weeks we will have better clarity on the pricing," Zydus Group Managing Director Sharvil Patel said in a virtual press conference.